99mTc-ImmuRAID-LL1 (Immunomedics)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug Name99mTc-ImmuRAID-LL1 (Immunomedics)
Drug Alias NameTC-99m-LL1
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment > Fab fragment
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsAutoimmune DiseasesArthritis, RheumatoidHodgkin Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesImmunomedics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesImmunomedics Inc
Active IndicationsN/A
Inactive IndicationsAutoimmune DiseasesArthritis, RheumatoidHodgkin Disease

Other Information

ATC CodeN/A
Related LinksN/A